Huahai awarded as "top 100 influential enterprises in China's pharmaceutical industry" and "top 20 R&D companies of China pharmaceutical group".
Recently,All-China Federation Of Industry&Commerce,Medical&Pharmaceutical Chamber released the most influential list of China's pharmaceutical industry in 2018. As a leading international enterprise in China's pharmaceutical industry, Huahai pharmaceutical has won two awards: "top 100 influential enterprises in China's pharmaceutical industry" and "top 20 r&d companies of China pharmaceutical group".
Since its establishment in 1989, Huahai pharmaceutical has always adhered to the core concept of"quality + innovation", promoted the rapid development of the enterprise with scientific and technological innovation, and enhanced product competitiveness with brand building, enhanced innovation ability and sustained development momentum, and realized the healthy, rapid and sustainable development of the enterprise.
In the future, the company will continue to promote intensive cultivation of the two industrial chains of pharmaceutical preparation and API, constantly improve and optimize the sales,research and development "two wings" system, and contribute to the progress of China's pharmaceutical industry.